Overall Score

Financial Distress Risk

Liquidity remains adequate with a current ratio of 2.27 and cash ratio of 1.75, but the company still carries operating losses and negative cash flow.

Profitability remains deeply negative with gross margin at -3.2%, operating margin at -33.3%, and net margin at -33.8%.

Interest coverage is severely negative at -57.3x, indicating ongoing distress despite modest leverage.

Dilution Capital Raise Risk

The company’s small market cap of about $4.7M leaves it highly exposed to future equity dilution or financing needs.

Negative free cash flow of about -$11.6M and negative operating cash flow continue to pressure capital resources.

Book value per share of $3.55 and cash per share of $3.10 provide some near-term cushion, but not enough to eliminate financing risk.

Operational Execution Risk

Revenue generation remains weak with asset turnover at 0.04 and revenue per share of just 0.28.

Working capital efficiency is poor, with a cash conversion cycle of 228 days and operating cycle of 371 days.

R&D spend remains high at about 19.9% of revenue, but it has not yet translated into positive operating performance.

Valuation Survival Optionality

The stock trades near book value at 1.01x P/B and below net current asset value, suggesting the market is pricing in significant execution risk.

EV/Sales of 7.85x is elevated relative to the company’s weak profitability and cash burn.

Net current asset value of about $1.24M offers limited downside support, but ongoing losses keep survival optionality constrained.